美國NovaBios

瘧疾（pf）檢測(cè)試劑盒（HRP-2/PLDH）

廣州健侖生物科技有限公司

本公司為大家供應(yīng)各種進(jìn)口品牌瘧疾（瘧原蟲）檢測(cè)試劑盒，包括美國的NovaBios、美國CORTEZ、美國BinaxNOW、韓國SD、廣州創(chuàng)侖等美國CDC品牌。主要包括膠體金、酶免、PCR等方法學(xué)。歡迎咨詢

非洲等熱帶國家工作用瘧疾（瘧原蟲）檢測(cè)試紙

泰國等熱帶疫情發(fā)生國家旅游用瘧疾（瘧原蟲）檢測(cè)試紙

惡性瘧原蟲、間日瘧原蟲、三日瘧原蟲、卵形瘧原蟲檢測(cè)試劑盒

進(jìn)口瘧疾檢測(cè)卡、瘧原蟲檢測(cè)試劑盒、瘧疾抗原檢測(cè)試劑盒

美國NovaBios瘧疾pf試紙 瘧疾抗原pf試紙 瘧疾抗原pf檢測(cè)試紙

要求在瘧疾消除道路的所有節(jié)點(diǎn)上開展有效監(jiān)測(cè)，且《2016-2030年瘧疾技術(shù)戰(zhàn)略》建議各國將監(jiān)測(cè)轉(zhuǎn)化為核心干預(yù)。需要大力監(jiān)測(cè)瘧疾，通過授權(quán)瘧疾規(guī)劃開展以下工作優(yōu)化規(guī)劃的運(yùn)作：
倡導(dǎo)與國家和次國家地區(qū)瘧疾疾病負(fù)擔(dān)相*的國內(nèi)和來源的投資；
調(diào)撥資源用于zui有需求的人群以及zui有效的干預(yù)措施，以便發(fā)揮zui大公共衛(wèi)生影響；
定期評(píng)估計(jì)劃是否按預(yù)期要求進(jìn)展，或者是否需要對(duì)干預(yù)措施的規(guī)?；蚪M合進(jìn)行調(diào)整；
報(bào)告資金使用效果，并使公眾與其選出的代表和捐助方能夠確定資金效益水平；
評(píng)價(jià)是否實(shí)現(xiàn)了規(guī)劃目標(biāo)，并了解哪些方面有效，以便能夠設(shè)計(jì)更高效率和效益的規(guī)劃。
急需建立更有力的瘧疾監(jiān)測(cè)系統(tǒng)，以便在瘧疾流行地區(qū)及時(shí)作出有效應(yīng)對(duì)，防止出現(xiàn)疫情和疾病卷土重來情況，跟蹤進(jìn)展，并使政府以及控瘧機(jī)構(gòu)和人士擔(dān)負(fù)起責(zé)任。

消除
消除瘧疾被定義為通過采取周密措施，在明確的地理區(qū)域阻斷由某種特定瘧原蟲引起的瘧疾當(dāng)?shù)貍鞑ァＰ枰^續(xù)采取措施預(yù)防重新傳播。（對(duì)某國作出的瘧疾消除認(rèn)證的要求是，阻斷由所有人類瘧原蟲導(dǎo)致的當(dāng)?shù)貍鞑ィ?br />消滅瘧疾指的是，通過采取周密措施，由人類瘧原蟲導(dǎo)致的瘧疾感染發(fā)病率永遠(yuǎn)降至零。疾病一旦被消滅，就不再要求采取干預(yù)措施。

美國NovaBios瘧疾pf試紙 瘧疾抗原pf試紙 瘧疾抗原pf檢測(cè)試紙

Called for effective monitoring on all nodes of the malaria eradication road, and the Global Strategy for Malaria in 2016-2030 recommended that countries transform monitoring into core interventions. There is a need for vigorous monitoring of malaria, through the authorization of malaria programs to carry out the following work to optimize the planning of the operation:
Advocacy of domestic and international sources of investment consistent with the burden of malaria disease in national and sub-national regions;
Allocate resources for the most needy and most effective interventions to maximize public health impacts;
Whether the program is scheduled to progress on a regular basis or whether it is necessary to adjust the size or combination of the intervention;
Report on the effectiveness of the use of funds and enable the public to determine the level of financial efficiency with the representatives and donors it elects;
Evaluate whether the planning objectives are met and what aspects are effective in order to be able to design more efficient and cost-effective planning.
There is an urgent need to establish a stronger malaria surveillance system in order to respond effectively to malaria-endemic areas in a timely manner to prevent the recurrence of outbreaks and diseases, to track progress and to assume responsibility for the Government and the global malaria control agencies and individuals.

eliminate
Elimination of malaria is defined as the adoption of careful measures to block the spread of malaria locally caused by a specific malaria parasite in a clear geographical area. There is a need to continue to take measures to prevent the re-transmission. (The requirement for malaria elimination certification for a country is to block the local spread caused by all human malaria parasites).
Elimination of malaria means that by taking careful measures, the global incidence of malaria infection caused by human malaria parasites has dropped to zero forever. Once the disease is eliminated, no intervention is required.

美國NovaBios瘧疾pf試紙

我司還提供其它進(jìn)口或國產(chǎn)試劑盒：登革熱、瘧疾、乙腦、寨卡、黃熱病、基孔肯雅熱、克錐蟲病、違禁品濫用、肺炎球菌、軍團(tuán)菌等試劑盒以及日本生研細(xì)菌分型診斷血清、德國SiFin診斷血清、丹麥SSI診斷血清等產(chǎn)品。

想了解更多的NovaBios產(chǎn)品及服務(wù)請(qǐng)掃描下方二維碼：

【公司名稱】 廣州健侖生物科技有限公司
【市場(chǎng)部】    楊永漢

【】 
【騰訊  】 2042552662
【公司地址】 廣州清華科技園創(chuàng)新基地番禺石樓鎮(zhèn)創(chuàng)啟路63號(hào)二期2幢101-103室